1. The Prognostic Significance of FGFR4 Gly388 Polymorphism in Esophageal Squamous Cell Carcinoma after Concurrent Chemoradiotherapy
    Hyun-Jeong Shim et al, 2016, Cancer Res Treat CrossRef
  2. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer
    Hao Chen, 2015, WJG CrossRef
  3. DFG-out Mode of Inhibition by an Irreversible Type-1 Inhibitor Capable of Overcoming Gate-Keeper Mutations in FGF Receptors
    Zhifeng Huang et al, 2015, ACS Chem. Biol. CrossRef
  4. Inhibition of thymidylate synthase affects neural tube development in mice
    Xiuwei Wang et al, 2017, Reproductive Toxicology CrossRef
  5. FGFR1 signaling potentiates tumor growth and predicts poor prognosis in esophageal squamous cell carcinoma patients.
    Baoqing Chen et al, 2018, Cancer Biol Ther CrossRef
  6. Antitumor effects and the underlying mechanism of licochalcone A combined with 5-fluorouracil in gastric cancer cells
    Xiaolin Lin et al, 2017 CrossRef
  7. Making way for suppressing the FGF19/FGFR4 axis in cancer
    Nestor Prieto-Dominguez et al, 2018, Future Medicinal Chemistry CrossRef
  8. TC-1 Overexpression Promotes Cell Proliferation in Human Non-Small Cell Lung Cancer that Can Be Inhibited by PD173074
    Jie Lei et al, 2014, PLoS ONE CrossRef
  9. Anti-LeY antibody enhances therapeutic efficacy of celecoxib against gastric cancer by downregulation of MAPKs/COX-2 signaling pathway: correlation with clinical study
    Faisal Aziz et al, 2015, J Cancer Res Clin Oncol CrossRef
  10. FGF-1/-3/FGFR4 signaling in cancer-associated fibroblasts promotes tumor progression in colon cancer through Erk and MMP-7
    Yu-Pan Bai et al, 2015, Cancer Sci CrossRef
  11. Ginsenoside Rg3 induces FUT4-mediated apoptosis in H. pylori CagA-treated gastric cancer cells by regulating SP1 and HSF1 expressions
    Faisal Aziz et al, 2016, Toxicology in Vitro CrossRef
  12. The over-expression of FGFR4 could influence the features of gastric cancer cells and inhibit the efficacy of PD173074 and 5-fluorouracil towards gastric cancer
    Jingjing Li et al, 2016, Tumor Biol. CrossRef
  13. A novel cell membrane affinity sample pretreatment technique for recognition and preconcentration of active components from traditional Chinese medicine
    Yusi Bu et al, 2017, Sci Rep CrossRef
  14. Fibroblast growth factor receptor 4 (FGFR4) and fibroblast growth factor 19 (FGF19) autocrine enhance breast cancer cells survival
    Kai Hung Tiong et al, 2016, Oncotarget CrossRef
  15. FGFR4 Inhibitor BLU9931 Attenuates Pancreatic Cancer Cell Proliferation and Invasion While Inducing Senescence: Evidence for Senolytic Therapy Potential in Pancreatic Cancer
    Norihiko Sasaki et al, 2020, Cancers CrossRef
  16. Partners in crime: The Lewis Y antigen and fucosyltransferase IV in Helicobacter pylori-induced gastric cancer
    Faisal Aziz et al, 2021, Pharmacology & Therapeutics CrossRef
  17. BLU-554, A selective inhibitor of FGFR4, exhibits anti-tumour activity against gastric cancer in vitro
    Xiangjian Zhang et al, 2022, Biochemical and Biophysical Research Communications CrossRef
  18. Induction of Fibroblast Growth Factor Receptor 4 by Helicobacter pylori via Signal Transducer and Activator of Transcription 3 With a Feedforward Activation Loop Involving Steroid Receptor Coactivator Signaling in Gastric Cancer
    Xing Zhang et al, 2022, Gastroenterology CrossRef
  19. FGFR4 Is a Potential Predictive Biomarker in Oral and Oropharyngeal Squamous Cell Carcinoma
    Koos Koole et al, 2015, Pathobiology CrossRef
  20. A novel small molecule RK-019 inhibits FGFR2-amplification gastric cancer cell proliferation and induces apoptosis in vitro and in vivo
    Jun Zeng et al, 2022, Front. Pharmacol. CrossRef
  21. FGF19/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2
    Meng Xie et al, 2023, Journal of Hepatology CrossRef
  22. FGFR and inhibitors
    Xiaokun Li, 2024 CrossRef
  23. Development of Chimeric Nanobody-Granzyme B Functionalized Ferritin Nanoparticles for Precise Tumor Therapy
    Baijin Xia et al, 2025, Pharmacological Research CrossRef